$GGAAF
NeuroMind AI Corp. Stock $ggaaf

$ggaaf Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023050090 Filed on June 20, 2023

Income Statement

Concept	2022 Q4	2022
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.521M	$3.297M
YoY Change	1915.69%	2895.0%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$1.521M	$120.0K
YoY Change	1915.69%	9.02%
Operating Profit		-$3.297M
YoY Change
Interest Expense	$2.145M	$3.634M
YoY Change	315367.65%	534380.88%
% of Operating Profit
Other Income/Expense, Net		$3.634M
YoY Change
Pretax Income	$624.6K	$337.9K
YoY Change	-935.29%	-408.87%
Income Tax
% Of Pretax Income
Net Earnings	$624.6K	$337.9K
YoY Change	-935.29%	-408.87%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	$0.02	$0.01
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.201M	$1.201M
YoY Change	-48.36%	-48.36%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets	$208.7K	$208.7K
YoY Change	372.97%	372.97%
Inventory
Prepaid Expenses	$208.7K
Receivables
Other Receivables
Total Short-Term Assets	$1.409M	$1.409M
YoY Change	-40.51%	-40.51%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$263.0M	$263.0M
YoY Change	2.4%	2.4%
Other Assets
YoY Change
Total Long-Term Assets	$263.0M	$263.0M
YoY Change	2.4%	2.4%
TOTAL ASSETS
Total Short-Term Assets	$1.409M	$1.409M
Total Long-Term Assets	$263.0M	$263.0M
Total Assets	$264.4M	$264.4M
YoY Change	2.01%	2.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.304M	$2.304M
YoY Change	620.68%	620.68%
Accrued Expenses	$675.7K	$675.7K
YoY Change	613.23%	613.25%
Deferred Revenue
YoY Change
Short-Term Debt	$2.530M	$2.530M
YoY Change	1009.26%	1009.26%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$19.42M	$19.42M
YoY Change	2923.48%	2923.46%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Total Long-Term Liabilities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$19.42M	$19.42M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$19.42M	$19.42M
YoY Change	33.43%	33.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$17.92M
YoY Change	46.99%
Common Stock	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$17.91M	$244.9M
YoY Change
Total Liabilities & Shareholders Equity	$264.4M	$264.4M
YoY Change	2.01%	2.01%

Cashflow Statement

Concept	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	$624.6K	$337.9K
YoY Change	-935.29%	-408.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$896.3K	-$896.3K
YoY Change	3399.92%	2652.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$1.406M	-$1.406M
YoY Change	-99.45%	-99.45%
Cash From Investing Activities	-$1.406M	-$1.406M
YoY Change	-99.45%	-99.45%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	2.302M	$2.302M
YoY Change	-99.11%	-99.11%
NET CHANGE
Cash From Operating Activities	-896.3K	-$896.3K
Cash From Investing Activities	-1.406M	-$1.406M
Cash From Financing Activities	2.302M	$2.302M
Net Change In Cash	-10.00	$0.00
YoY Change	-100.0%	-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$896.3K	-$896.3K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41138
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1601264
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	Bahnhofstrasse 3
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Hergiswil Nidwalden
CY2022	dei	Entity Address Country EntityAddressCountry	CH
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	6052
CY2022	dei	City Area Code CityAreaCode	+41
CY2022	dei	Local Phone Number LocalPhoneNumber	78 607 99 01
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2022	dei	Auditor Firm AuditorFirmId	206
CY2022	dei	Auditor Name AuditorName	MaloneBailey, LLP
CY2022	dei	Auditor Location AuditorLocation	Houston, Texas
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	true
CY2022Q4	dei	Entity Public Float EntityPublicFloat	262800000	usd
CY2022Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	1200595	usd
CY2021Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	2325000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	208721	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	44133	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	1409316	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	2369133	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	262960151	usd
CY2021Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	256795678	usd
CY2022Q4	us-gaap	Assets Assets	264369467	usd
CY2021Q4	us-gaap	Assets Assets	259164811	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2303503	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	319628	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	675727	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	94742	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	2530000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	228077	usd
CY2022Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	13915000	usd
CY2021Q4	us-gaap	Deferred Income Current DeferredIncomeCurrent	0	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	19424230	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	642447	usd
CY2021Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent	13915000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	19424230	usd
CY2021Q4	us-gaap	Liabilities Liabilities	14557447	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	262860151	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	256795000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	ggaa	Common Stock Value1 CommonStockValue1	633	usd
CY2021Q4	ggaa	Common Stock Value1 CommonStockValue1	633	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-17915547	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12188269	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-17914914	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12187636	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	264369467	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	259164811	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3176600	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	100069	usd
CY2022	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	120000	usd
	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	10000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-3296600	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-110069	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	3634473	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	678	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3634473	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	678	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	337873	usd
	us-gaap	Net Income Loss NetIncomeLoss	-109391	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	253000000	usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	8875000	usd
	us-gaap	Partners Capital Account Public Sale Of Units Net Of Offering Costs PartnersCapitalAccountPublicSaleOfUnitsNetOfOfferingCosts	17183245	usd
	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	256795000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-109391	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-12187636	usd
CY2022	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	6065151	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	337873	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-17914914	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	337873	usd
	us-gaap	Net Income Loss NetIncomeLoss	-109391	usd
CY2022	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	3634473	usd
	us-gaap	Gain On Sale Of Investments GainOnSaleOfInvestments	678	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	164588	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	44133	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1983875	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	96888	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	580985	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24742	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-896328	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-32572	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-1124405	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	2325000	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	2530000	usd
	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	256795000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1405595	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-259120000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	228077	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	200000	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2530000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	453077	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	8875000	usd
	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	253000000	usd
	ggaa	Offering Costs Paid OfferingCostsPaid	-2975505	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2301923	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	259152572	usd
	ggaa	Offering Costs Paid By Related Party Under Promissory Note OfferingCostsPaidByRelatedPartyUnderPromissoryNote	25000	usd
	ggaa	Offering Costs Included In Accounts Payable OfferingCostsIncludedInAccountsPayable	222740	usd
	ggaa	Deferred Offering Costs Included In Accrued Expenses DeferredOfferingCostsIncludedInAccruedExpenses	70000	usd
	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	13915000	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	2530000	usd
	ggaa	Fair Value Of Class B Ordinary Shares Sold By Sponsor To Nomura At Initial Public Offering FairValueOfClassBOrdinarySharesSoldBySponsorToNomuraAtInitialPublicOffering	256795000	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	6065151	usd
CY2021Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	10
CY2021Q4	ggaa	Stock Issued During Period Value New Issues1 StockIssuedDuringPeriodValueNewIssues1	33000000	usd
CY2021Q4	ggaa	Offering Costs OfferingCosts	2100000	usd
CY2021Q4	us-gaap	Amortization Of Deferred Sales Commissions AmortizationOfDeferredSalesCommissions	1800000	usd
CY2022	us-gaap	Costs Incurred Exploration Costs CostsIncurredExplorationCosts	100000	usd
CY2022	ggaa	Fair Value Percentage FairValuePercentage	0.80	pure
CY2022	ggaa	Public Share Price PublicSharePrice	10.29
CY2022	ggaa	Dissolution Expenses DissolutionExpenses	100000	usd
CY2022Q4	us-gaap	Excess Capital ExcessCapital	4100000	usd
CY2022	us-gaap	Payments For Loans PaymentsForLoans	453000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4	us-gaap	Deposit Assets DepositAssets	2530000	usd
CY2022Q4	ggaa	Trust Account To Pay TrustAccountToPay	263325414	usd
CY2022Q4	ggaa	Trust Account Per Share TrustAccountPerShare	10.45
CY2022	us-gaap	Sale Of Stock Consideration Received Per Transaction SaleOfStockConsiderationReceivedPerTransaction	150000000	usd
CY2022	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	12650000	shares
CY2022	ggaa	Private Placement Warrants PrivatePlacementWarrants	8875000	shares
CY2021Q4	us-gaap	Demutualization By Insurance Entity Securities Issued Gross Cash Proceeds DemutualizationByInsuranceEntitySecuritiesIssuedGrossCashProceeds	220000000	usd
CY2021Q4	us-gaap	Preferred Units Offering Costs PreferredUnitsOfferingCosts	19000000	usd
CY2021Q4	ggaa	Underwriting Fees UnderwritingFees	12100000	usd
CY2021Q4	us-gaap	Accounts Payable Underwriters Promoters And Employees Other Than Salaries And Wages Current AccountsPayableUnderwritersPromotersAndEmployeesOtherThanSalariesAndWagesCurrent	3300000	usd
CY2022	ggaa	Offering Price OfferingPrice	10
CY2022	ggaa	Additional Offering Cost AdditionalOfferingCost	2100000	usd
CY2022	ggaa	Deferred Underwriting Commission DeferredUnderwritingCommission	1800000	usd
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	825000	shares
CY2021Q4	ggaa	Purchase An Additional Units PurchaseAnAdditionalUnits	3300000	shares
CY2021Q4	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	825000	shares
CY2021Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	25000	usd
CY2022Q4	us-gaap	Other Additional Capital OtherAdditionalCapital	453000	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	200000	usd
CY2021Q4	us-gaap	Notes Receivable Related Parties Current NotesReceivableRelatedPartiesCurrent	25000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	228000	usd
CY2022Q4	ggaa	Trust Account To Pay TrustAccountToPay	2530000	usd
CY2022	ggaa	Working Capital Debt WorkingCapitalDebt	1500000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	120000	usd
	us-gaap	Operating Expenses OperatingExpenses	10000	usd
CY2022	ggaa	Outstanding Balance OutstandingBalance	130000	usd
	ggaa	Outstanding Balance OutstandingBalance	10000	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	1200595	usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party Current RelatedPartyTransactionDueFromToRelatedPartyCurrent	2325000	usd
CY2022	ggaa	Underwriting Discount UnderwritingDiscount	0.1
CY2022	ggaa	Additional Per Unit AdditionalPerUnit	0.55
CY2022	ggaa	Additional Aggregate Underwriters AdditionalAggregateUnderwriters	13900000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	ggaa	Converted Percentage ConvertedPercentage	0.20	pure
CY2022	ggaa	Public Warrants Exercisable PublicWarrantsExercisable	11.5
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2022	ggaa	Effective Issue Price EffectiveIssuePrice	9.2
CY2022Q4	ggaa	Total Equity Proceeds Percentage TotalEquityProceedsPercentage	0.60	pure
CY2022	ggaa	Market Value Percentage MarketValuePercentage	1.15	pure
CY2022Q4	ggaa	Redemption Of Warrant Per Share Price RedemptionOfWarrantPerSharePrice	18
CY2022	ggaa	Newly Issued Price NewlyIssuedPrice	1.80	pure
CY2022	us-gaap	Debt Instrument Redemption Description DebtInstrumentRedemptionDescription	Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00Once the warrants become exercisable, the Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): ●in whole and not in part; ●at a price of $0.01 per warrant; ●upon a minimum of 30 days’ prior written notice of redemption; and ●if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders.
CY2022Q4	us-gaap	Debt Instrument Repurchase Amount DebtInstrumentRepurchaseAmount	2530000	usd
CY2022	ggaa	Redeem Ordinary Shares RedeemOrdinaryShares	25198961	shares
CY2022Q4	ggaa	Issued And Outstanding Percentage IssuedAndOutstandingPercentage	0.996	pure
CY2022	dei	Entity Registrant Name EntityRegistrantName	Genesis Growth Tech Acquisition Corp.
CY2022Q4	us-gaap	Deferred Income Noncurrent DeferredIncomeNoncurrent		usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity		usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2022	ggaa	Offering Costs Paid By Related Party Under Promissory Note OfferingCostsPaidByRelatedPartyUnderPromissoryNote		usd
CY2022	us-gaap	Other Underwriting Expense OtherUnderwritingExpense		usd
	us-gaap	Stock Issued1 StockIssued1		usd
CY2022	ggaa	Fair Value Of Class B Ordinary Shares Sold By Sponsor To Nomura At Initial Public Offering FairValueOfClassBOrdinarySharesSoldBySponsorToNomuraAtInitialPublicOffering		usd
	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001865697

Files In Submission

Name	View Source	Status
0001213900-23-050090-index-headers.html	Edgar Link	pending
0001213900-23-050090-index.html	Edgar Link	pending
0001213900-23-050090.txt	Edgar Link	pending
0001213900-23-050090-xbrl.zip	Edgar Link	pending
f10k2022ex31-1_genesis.htm	Edgar Link	pending
f10k2022ex31-2_genesis.htm	Edgar Link	pending
f10k2022ex32-1_genesis.htm	Edgar Link	pending
f10k2022ex32-2_genesis.htm	Edgar Link	pending
f10k2022_genesisgrowth.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ggaa-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
ggaa-20221231_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ggaa-20221231_def.xml	Edgar Link	unprocessable
ggaa-20221231_pre.xml	Edgar Link	unprocessable
ggaa-20221231_lab.xml	Edgar Link	unprocessable
f10k2022_genesisgrowth_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GGAAF
NeuroMind AI Corp. Stock $ggaaf

2022 Q4 Form 10-K Financial Statement

#000121390023050090 Filed on June 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GGAAF NeuroMind AI Corp. Stock $ggaaf

2022 Q4 Form 10-K Financial Statement

#000121390023050090 Filed on June 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GGAAF
NeuroMind AI Corp. Stock $ggaaf